Instead of just killing off cancer cells directly, chemotherapy works because it prompts the body's own defenses to destroy tumor cells, new research in mice suggests.
The findings, published April 4 in the journal Immunity, suggest the immune system plays a critical role in fighting cancer.
"You need the host immune system — the reaction against the tumor — to work," said study co-author Guido Kroemer, an immunologist at the National Institute of Health and Medical Research in France.
If follow-up studies in people show a similar effect, doctors could boost the immune response to increase chemotherapy's effectiveness or measure a patient's immune response to specific drugs to predict chemotherapy's success, Kroemer told LiveScience.
Until now, scientists had a limited understanding of how chemotherapy works. They assumed that the treatment worked by selectivelykilling more tumor cells than healthy cells, Kroemer said.
But the immune system also seemed to play a role. For instance, past work showed that chemotherapy required a particular immune cell type — called T-lymphocytes, or T-cells — in order to work against breast cancer.
To understand how T-lymphocytes identified tumor cells, Kroemer and his colleagues marked cancer cells in mice with a protein that glowed green. They then watched what happened to those cells after they gave the mice an anthracycline, a specific type of chemotherapy. Anthracyclines are used to treat breast cancer, as well as prostate and lung cancer.
The researchers found that specific immune cells were drawn to a chemical signal from the tumor cells and then presented them to the T-lymphocyte immune cells.
To show that this cell played a key role in chemo's effectiveness, the team showed that mice lacking these presenting molecules had a marked reduction in chemotherapy response.
The research suggests that the immune system may play a wider role in fighting cancer than previously thought, Kroemer said.
Live Science newsletter
Stay up to date on the latest science news by signing up for our Essentials newsletter.
Tia is the managing editor and was previously a senior writer for Live Science. Her work has appeared in Scientific American, Wired.com and other outlets. She holds a master's degree in bioengineering from the University of Washington, a graduate certificate in science writing from UC Santa Cruz and a bachelor's degree in mechanical engineering from the University of Texas at Austin. Tia was part of a team at the Milwaukee Journal Sentinel that published the Empty Cradles series on preterm births, which won multiple awards, including the 2012 Casey Medal for Meritorious Journalism.